2013 IPO
Savara
$2.549876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.09 (-3.41%) As of 3:12 PM EDT today
-$0.09 (-3.41%) Today
Why Robinhood?
You can buy or sell Savara and other stocks, options, ETFs, and crypto commission-free!
About SVRA
Savara Inc. Common Stock, also called Savara, is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Read More Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.
Employees
33
Headquarters
Austin, Texas
Founded
2017
Market Cap
94.23M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
307.20K
High Today
$2.63
Low Today
$2.53
Open Price
$2.62
Volume
185.28K
52 Week High
$13.25
52 Week Low
$2.32
Collections
2013 IPO
SVRA News
Price Paid on Robinhood
64% Lower
Right Now
52 Week Low
$2.32
Average Price Paid
$7.12
52 Week High
$13.25
Analyst Ratings
67%
of 6 ratings
Buy
67%
Hold
33%
Sell
0%
SVRA Earnings
-$0.88
-$0.66
-$0.45
-$0.23
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, After Hours